Neutrophil CD64 is upregulated in RA patients with lymphoma but not in other solid cancers-Reference-Cited by-同舟云学术

Neutrophil CD64 is upregulated in RA patients with lymphoma but not in other solid cancers

Published:2015-09-18 Issue:2 Volume:26 Page:216-223
ISSN:1439-7595
Container-title:Modern Rheumatology
language:en
Short-container-title:Modern Rheumatology

Author:

Komiya Akiko¹,Matsui Toshihiro²,Horie Koichiro²,Fukuda Hidefumi²,Iwata Kanako³,Tsuno Hirotaka²,Ogihara Hideki²,Ikenaka Tatsuoh⁴,Kawakami Misato²,Furukawa Hiroshi³,Hashimoto Atsushi²,Hirai Kotaro⁵,Tohma Shigeto³

Affiliation:

1. Department of Clinical Laboratory, Sagamihara National Hospital, National Hospital Organization, Kanagawa, Japan,

2. Department of Rheumatology, Sagamihara National Hospital, National Hospital Organization, Kanagawa, Japan,

3. Department of Rheumatology, Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, National Hospital Organization, Kanagawa, Japan,

4. Department of Rehabilitation, Sagamihara National Hospital, National Hospital Organization, Kanagawa, Japan, and

5. Department of Urology, Sagamihara National Hospital, National Hospital Organization, Kanagawa, Japan

Publisher

Informa UK Limited

Subject

Rheumatology

Link

https://www.tandfonline.com/doi/pdf/10.3109/14397595.2015.1078986

Reference39 articles.

1. FEVER OF UNEXPLAINED ORIGIN: REPORT ON 100 CASES

2. Fever of Unknown Origin (FUO): I. A prospective multicenter study of 167 patients with FUO, using fixed epidemiologic entry criteria

3. A Comprehensive Evidence-Based Approach to Fever of Unknown Origin

4. Febrile infection changes the expression of IgG Fc receptors and complement receptors in human neutrophils in vivo

5. Neutrophils from Term and Preterm Newborn Infants Express the High Affinity Fcγ-Receptor I (CD64) During Bacterial Infections

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Utility of Neutrophil CD64 to Detect Extrapulmonary Tuberculosis in Three Patients with Rheumatoid Arthritis Undergoing Treatment with Biologics;Case Reports in Rheumatology;2018-12-06

2. Methotrexate;Reactions Weekly;2016-05